blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1471917

EP1471917 - USE OF PDE5 INHIBITORS SUCH AS SILDENAFIL IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.09.2006
Database last updated on 15.06.2024
Most recent event   Tooltip29.09.2006Application deemed to be withdrawnpublished on 02.11.2006  [2006/44]
Applicant(s)For:GB 
Pfizer Limited
261 Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
For:AT  BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GR  HU  IE  IT  LI  LU  MC  NL  PT  SE  SI  SK  TR 
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
[N/P]
Former [2006/29]For:GB 
Pfizer Limited
261 Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
For:AT  BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GR  HU  IE  IT  LI  LU  MC  NL  PT  SE  SI  SK  TR 
PFIZER INC.
235 East 42nd Street
New York, N.Y. 10017 / US
Former [2004/45]For:GB 
Pfizer Limited
261 Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
For:AT  BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GR  HU  IE  IT  LU  MC  NL  PT  SE  SI  SK  TR 
PFIZER INC.
235 East 42nd Street
New York, N.Y. 10017 / US
Inventor(s)01 / GHAZZI, Mahmoud Nizar, Pfizer Global Res. & Dev.
Ann Arbor Laboratories, 2800 Plymouth Road
Ann Arbor, MI 48105 / US
02 / KOPPIKER, Nandan, Parmanand, Pfizer Global Res.&Dev
Ramsgate Road
Sandwich, Kent CT139NJ / GB
03 / WESTBROOK, Simon, Lempriere, Pfizer Global Res.&Dev
Ramsgate Road
Sandwich, Kent CT139NJ / GB
 [2004/45]
Representative(s)Nevant, Marc, et al
Pfizer
European Patent Department
23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
[N/P]
Former [2006/16]Nevant, Marc, et al
Pfizer European Patent Department 23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
Former [2004/45]Motion, Keith Robert
Pfizer Limited, European Pharma Patent Department, Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Application number, filing date03702809.927.01.2003
[2004/45]
WO2003IB00257
Priority number, dateUS20020355038P07.02.2002         Original published format: US 355038 P
[2004/45]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03066061
Date:14.08.2003
Language:EN
[2003/33]
Type: A1 Application with search report 
No.:EP1471917
Date:03.11.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 14.08.2003 takes the place of the publication of the European patent application.
[2004/45]
Search report(s)International search report - published on:EP14.08.2003
ClassificationIPC:A61K31/519, A61K31/155, A61P15/00
[2004/45]
CPC:
A61K31/155 (EP,US); A61K31/519 (EP,US); A61P15/00 (EP);
A61P15/08 (EP); A61P43/00 (EP); C07D487/04 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2004/45]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
TitleGerman:VERWENDUNG VON PDE5 INHIBITOREN, VOR ALLEM SILDENAFIL IN DER BEHANDLUNG VON POLYZYSTISCHEN OVARIALSYNDROM[2004/45]
English:USE OF PDE5 INHIBITORS SUCH AS SILDENAFIL IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME[2004/45]
French:UTILISATION D'INHIBITEURS PDE5, TEL QUE LE SILDENAFIL, DANS LE TRAITEMENT DU SYNDROME D'OVAIRE POLYKYSTIQUE[2004/45]
Entry into regional phase02.08.2004National basic fee paid 
02.08.2004Designation fee(s) paid 
02.08.2004Examination fee paid 
Examination procedure10.03.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
02.08.2004Examination requested  [2004/45]
24.10.2005Despatch of a communication from the examining division (Time limit: M06)
04.05.2006Application deemed to be withdrawn, date of legal effect  [2006/44]
08.06.2006Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2006/44]
Fees paidRenewal fee
07.01.2005Renewal fee patent year 03
09.01.2006Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[PX]WO0213798  (PFIZER LTD [GB], et al) [PX] 1-13 * abstract * * page 1, line 23 - page 2, line 8 * * claims 1-61 *;
 [XY]US6242474  (YAMASAKI NORITSUGU [JP], et al) [X] 1-13 * abstract * [Y] 4,10-13;
 [XY]  - "Viagra treatment for female infertility:", PHIND, (20000503), XP002167738 [X] 1-13 * abstract * [Y] 4,10-13
 [Y]  - GLUECK C J ET AL, "Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).", THE JOURNAL OF ADOLESCENT HEALTH: OFFICIAL PUBLICATION OF THE SOCIETY FOR ADOLESCENT MEDICINE. UNITED STATES SEP 2001, (200109), vol. 29, no. 3, ISSN 1054-139X, pages 160 - 169, XP001152926 [Y] 4,10-13 * abstract *

DOI:   http://dx.doi.org/10.1016/S1054-139X(01)00202-6
 [Y]  - PUGEAT M ET AL, "Insulin resistance, polycystic ovary syndrome and metformin.", DRUGS. NEW ZEALAND 1999, (1999), vol. 58 Suppl 1, ISSN 0012-6667, pages 41 - 46;discussion 75 - 82, XP009012355 [Y] 4,10-13 * abstract *

DOI:   http://dx.doi.org/10.2165/00003495-199958001-00010
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.